Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Metastatic Cutaneous Squamous Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
... Cutaneous Squamous Cell Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic Cutaneous Squamous Cell Carcinoma market report provides current treatment practices, emerging drugs, Metastatic ... Read More
-
Metastatic HER2 positive breast cancer - Market Insight, Epidemiology and Market Forecast -2032
... HER2 positive breast cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metastatic HER2 positive breast cancer market report provides current treatment practices, emerging drugs, Metastatic ... Read More
-
NK Cell therapies - Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage NK ... Read More
-
Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Lung Adenocarcinoma - Epidemiology Forecast - 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Lung Adenocarcinoma Understanding The DelveInsight Lung Adenocarcinoma ... Read More
-
Lip and Oral Cavity Cancer - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Lip ... Read More
-
Hodgkin's lymphoma (HL) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Hodgkin's lymphoma (HL) Understanding The ... Read More
-
Esophageal Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Esophageal Cancer Understanding The DelveInsight Esophageal Cancer ... Read More
-
Ductal Carcinoma in Situ - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Ductal Carcinoma in ... Read More
-
HER+ Gastric Cancer - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HER+ Gastric Cancer Understanding The ... Read More
-
Thyroid Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Thyroid Cancer Understanding The DelveInsight Thyroid Cancer ... Read More
-
HR-Positive-HER-negative - Epidemiology Forecast to 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HR-Positive-HER-negative Understanding The DelveInsight HR-Positive-HER-negative epidemiology report gives a ... Read More
-
Merkel Cell Carcinoma - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Merkel Cell Carcinoma Understanding The ... Read More
-
ESR1 Mutated Metastatic Breast Cancer - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 ESR1 ... Read More
-
Medullary Thyroid Cancer - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Medullary Thyroid Cancer Understanding The ... Read More
-
Prostate cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Prostate cancer Understanding The DelveInsight Prostate cancer ... Read More
-
Ovarian Clear Cell Carcinoma - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Ovarian Clear Cell ... Read More
-
Multiple Myeloma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Multiple Myeloma Understanding The DelveInsight Multiple Myeloma ... Read More
-
Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022
... Diagnostics market in the 7 major pharmaceutical markets. The report also gives a brief competitive analysis of both the current and emerging products, to help understand the competition in the market. Liquid Biopsy for Cancer ... Read More
-
MLLr and NPM1c Mutant Relapsed/Refractory (R/R) Acute Leukemia - Epidemiology Forecast - 2032
... epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) ... Read More
-
Hairy Cell Leukemia (HCL) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Hairy Cell Leukemia ... Read More
-
Metastatic Hormone Refractory Prostate Cancer - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic ... Read More
-
Cancer Pain - Epidemiology Forecast - 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Cancer Pain Understanding The DelveInsight Cancer Pain ... Read More
-
Gastric Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gastric Cancer Understanding The DelveInsight Gastric Cancer ... Read More
-
Metastatic Uveal Melanoma (MUM) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic Uveal Melanoma ... Read More
Research Assistance
